Similar to the favourable prognostic value, the positive predictive role of CD20+ TILs was independent of CD3+ and/or CD8+ TILs [34,35,38], lending support to the significance of B cell immunity on top of CMI in breast cancer. The gene discussed is CD8A; the disease is breast cancer.